# Cyproheptadine Hydrochloride

NDC: 50268-201
Generic name: Cyproheptadine Hydrochloride
Labeler / Manufacturer: AvPAK
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20251030

FDA application: ANDA040537

## Active ingredients

- CYPROHEPTADINE HYDROCHLORIDE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50268-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50268-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=426acecc-aef4-099c-e063-6294a90a54eb
